FitLife Brands (FTLF) Competitors $15.37 +0.27 (+1.79%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$15.40 +0.03 (+0.20%) As of 05/1/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. SION, KURA, OPT, PRTA, URGN, STOK, MRVI, VERV, GHRS, and MNMDShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Sionna Therapeutics (SION), Kura Oncology (KURA), Opthea (OPT), Prothena (PRTA), UroGen Pharma (URGN), Stoke Therapeutics (STOK), Maravai LifeSciences (MRVI), Verve Therapeutics (VERV), GH Research (GHRS), and Mind Medicine (MindMed) (MNMD). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Sionna Therapeutics Kura Oncology Opthea Prothena UroGen Pharma Stoke Therapeutics Maravai LifeSciences Verve Therapeutics GH Research Mind Medicine (MindMed) Sionna Therapeutics (NASDAQ:SION) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, community ranking and media sentiment. Does the MarketBeat Community prefer SION or FTLF? Sionna Therapeutics and FitLife Brands both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave Sionna Therapeutics an outperform vote while only 60.00% of users gave FitLife Brands an outperform vote. CompanyUnderperformOutperformSionna TherapeuticsOutperform Votes3100.00% Underperform VotesNo VotesFitLife BrandsOutperform Votes360.00% Underperform Votes240.00% Do analysts rate SION or FTLF? Sionna Therapeutics currently has a consensus target price of $38.50, indicating a potential upside of 198.45%. FitLife Brands has a consensus target price of $20.50, indicating a potential upside of 33.38%. Given Sionna Therapeutics' higher probable upside, research analysts clearly believe Sionna Therapeutics is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Is SION or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to Sionna Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Sionna Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sionna TherapeuticsN/A N/A N/A FitLife Brands 13.38%28.03%15.13% Which has preferable valuation & earnings, SION or FTLF? FitLife Brands has higher revenue and earnings than Sionna Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSionna TherapeuticsN/AN/AN/AN/AN/AFitLife Brands$64.47M2.20$5.30M$0.8418.30 Does the media prefer SION or FTLF? In the previous week, Sionna Therapeutics and Sionna Therapeutics both had 3 articles in the media. Sionna Therapeutics' average media sentiment score of 0.84 beat FitLife Brands' score of 0.29 indicating that Sionna Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sionna Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of SION or FTLF? 2.3% of FitLife Brands shares are owned by institutional investors. 61.3% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryFitLife Brands beats Sionna Therapeutics on 8 of the 12 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$141.70M$1.16B$5.47B$7.92BDividend YieldN/AN/A5.11%4.22%P/E Ratio18.1910.0722.5118.54Price / Sales2.2010.21397.62103.35Price / Cash19.0510.4038.1834.62Price / Book5.061.466.734.25Net Income$5.30M-$54.34M$3.22B$248.18M7 Day Performance10.97%3.14%1.58%1.25%1 Month Performance29.70%25.96%4.05%3.76%1 Year Performance8.70%-35.54%15.75%5.28% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.1629 of 5 stars$15.37+1.8%$20.50+33.4%+8.7%$141.70M$64.47M18.1920Short Interest ↑SIONSionna TherapeuticsN/A$12.04-0.8%$38.50+219.8%N/A$531.25MN/A0.0035Positive NewsGap DownKURAKura Oncology4.1317 of 5 stars$6.51+1.2%$25.50+291.7%-68.0%$525.87M$53.88M-2.76130Analyst ForecastNews CoverageOPTOpthea0.911 of 5 stars$3.41+7.2%$1.33-60.9%+0.9%$524.84M$87,666.000.008News CoverageGap UpPRTAProthena3.4234 of 5 stars$9.65-0.5%$55.00+469.9%-59.3%$519.43M$135.16M-4.20130Upcoming EarningsURGNUroGen Pharma4.2958 of 5 stars$11.26+14.1%$32.86+191.8%-20.8%$519.02M$90.40M-3.57200Analyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeSTOKStoke Therapeutics3.5108 of 5 stars$9.47-3.0%$24.67+160.5%-14.6%$517.03M$36.56M-4.51100Upcoming EarningsPositive NewsMRVIMaravai LifeSciences4.0223 of 5 stars$2.01-2.0%$6.34+215.6%-75.9%$511.22M$259.19M-1.23610Upcoming EarningsOptions VolumeVERVVerve Therapeutics3.7296 of 5 stars$5.73-0.5%$25.75+349.4%-8.3%$508.80M$32.33M-2.33110Positive NewsGHRSGH Research1.9531 of 5 stars$9.40-1.4%$30.86+228.3%-9.9%$489.06MN/A-11.9010News CoveragePositive NewsMNMDMind Medicine (MindMed)2.3047 of 5 stars$6.36+2.1%$25.11+294.8%-30.1%$479.34MN/A-2.8140Upcoming Earnings Related Companies and Tools Related Companies Sionna Therapeutics Competitors Kura Oncology Competitors Opthea Competitors Prothena Competitors UroGen Pharma Competitors Stoke Therapeutics Competitors Maravai LifeSciences Competitors Verve Therapeutics Competitors GH Research Competitors Mind Medicine (MindMed) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.